Literature DB >> 227788

Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing.

R A Proctor.   

Abstract

Endotoxin was shown to depress neutrophil bactericidal activity while enhancing Nitro Blue Tetrazolium reduction and hexose monophosphate shunt activity. Separation of bactericidal action from oxidative metabolism suggests that the effect of endotoxin might involve the formation of reactive oxygen radicals such as superoxide. Chemiluminescence often accompanies metabolic activation of polymorphonuclear neutrophils (PMNs). However, human PMNs did not show chemiluminescence when challenged with endotoxin (lipopolysaccharide; LPS) or lipid A. Superoxide formation was also unaffected by endotoxin. In contrast, preincubation of PMNs with LPS for 30 min produced significant depression of chemiluminescence, oxygen consumption, and superoxide formation. Decreased chemiluminescence was not the result of complement consumption. In a cell-free system, superoxide was not scavenged by LPS, nor did LPS stimulate superoxide dismutase. Oxidase enzymes for reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate harvested from broken cells were not affected by LPS. The toxicity of LPS may reside in its ability to activate the PMNs while simultaneously blocking bactericidal capacity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227788      PMCID: PMC414534          DOI: 10.1128/iai.25.3.912-921.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Symposium on bacterial endotoxins. III. Metabolic effects of endotoxins on mammalian cells.

Authors:  M W WOODS; M LANDY; J L WHITBY; D BURK
Journal:  Bacteriol Rev       Date:  1961-12

2.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

3.  Xanthine oxidase. IV. Participation of iron in internal electron transport.

Authors:  I FRIDOVICH; P HANDLER
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

4.  Occurrence and control of the phosphogluconate oxidation pathway in normal and leukemic leukocytes.

Authors:  W S BECK
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

5.  The metabolism of human polymorphonuclear leukocytes.

Authors:  S P MARTIN; G R MCKINNEY; R GREEN
Journal:  Ann N Y Acad Sci       Date:  1955-03-24       Impact factor: 5.691

6.  Oxygen-dependent microbial killing by phagocytes (second of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

7.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Initiation of the respiratory burst in human polymorphonuclear neutrophils: a critical review.

Authors:  L R DeChatelet
Journal:  J Reticuloendothel Soc       Date:  1978-07

9.  Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; P S Shirley; L C McPhail; D B Iverson; G J Doellgast
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

10.  Functional and metabolic properties of polymorphonuclear leucocytes. II. The influence of a lipopolysaccharide endotoxin.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307

View more
  21 in total

1.  Failure of lipopolysaccharides to directly trigger the chemiluminescence response of isolated equine polymorphonuclear leukocytes.

Authors:  H Benbarek; G Deby-Dupont; I Caudron; C Deby; M Lamy; D Serteyn
Journal:  Vet Res Commun       Date:  1997-10       Impact factor: 2.459

2.  Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha.

Authors:  P Koivuranta-Vaara; D Banda; I M Goldstein
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  The rate of oxygen utilization by cells.

Authors:  Brett A Wagner; Sujatha Venkataraman; Garry R Buettner
Journal:  Free Radic Biol Med       Date:  2011-05-27       Impact factor: 7.376

4.  Serum-mediated depression of neutrophil chemiluminescence following blunt trauma.

Authors:  M E Lanser; P Mao; G Brown; B Coleman; J H Siegel
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  Role of fibronectin in human monocyte and macrophage bactericidal activity.

Authors:  R A Proctor; J A Textor; J M Vann; D F Mosher
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

6.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors.

Authors:  K T Hartiala; L Langlois; I M Goldstein; J T Rosenbaum
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Direct and indirect effects of E. coli lipopolysaccharide on isolated human polymorphonuclear granulocytes and mixed leukocytes.

Authors:  H Opdahl
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

9.  Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides.

Authors:  A Kapp; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli.

Authors:  M B Goetz; F J Silverblatt
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.